Peking University Resources (Holdings) Company Limited

What Peking University Resources (Holdings) Company Limited does

Peking University Resources (Holdings) Company Limited (SEHK:618) is a Hong Kong-listed diversified holding company that has undergone a strategic transformation from a traditional mainland China real estate developer into a multi-segment group anchored on healthcare and digital businesses. The company was founded in 1975, suspended trading in April 2021 following the liquidation of associated entity Fangzheng Information, and successfully resumed trading on August 11, 2022 after completing required restructuring under new ownership led by Chairman Huang Qihao (黄启豪).

The company's core healthcare franchise is built around the 葉開泰 (Ye Kai Tai) brand, a 400-year-old China Time-Honored Brand (中華老字號) and one of China's four famous traditional Chinese medicine pharmacies. Following the November 2023 acquisition of Wuhan Ye Kai Tai Pharmaceutical Chain Co., Ltd., the company operates 41 chain pharmacies, 11 TCM clinics, and 1 distribution center in Wuhan, plus a TCM integrative clinic in Hangzhou. The healthcare business is being digitized through the 葉開泰健康 AI mini-program (globally launched October 2025), a strategic partnership with MedGPT (医联集团) for AI-powered medical consultation, and the ResoHealth/LetsGo digital health platform (with DNA epigenetic testing, Vigorous AI management, insurance brokerage, and data services) targeting overseas markets in the Middle East.

The group operates five strategic business divisions: real estate tech + green buildings, internet + healthcare, digital e-commerce, asset management + financial services, and super brand digital operations. The asset management division leverages a Hong Kong SFC Type 9 license obtained in April 2023. The digital e-commerce business serves as a "super brand digital operations partner" for brands including Gree, Sharp, Jiuyang, Keyixiu, and Yuanben Life, distributing across 32+ cities with 10,000+ channel partners. In FY2023 (year ending March 31, 2023), the company reported revenue of RMB 5.175 billion (down 56% YoY due to reduced property deliveries) and profit of approximately RMB 1.02 billion (a 334.93% YoY turnaround). The company also explores Web3.0 and metaverse strategies through NFT issuance (滋圓 series), the Captain源 IP, and an investment of up to USD 2 million in Nibiru Global Limited for blockchain-based virtual real estate.

Name

Peking University Resources (Holdings) Company Limited

Legal name

北大资源（控股）有限公司

Website

https://pkurh.com

Company type

Public

Founded year

1975

Operating status

Operating

Short description

Peking University Resources (Holdings) Company Limited (SEHK:618) is a Hong Kong-listed holding company pivoting from real estate into a multi-segment group anchored on the 400-year-old 葉開泰 TCM healthcare brand, AI-powered digital health platforms (ResoHealth, MedGPT integration), digital e-commerce for brand partners, and regulated asset management.

Ownership category

akta.pro rank

Product category

Traditional Chinese Medicine Healthcare and Digital Health

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421), All Other Health and Personal Care Retailers (456199)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Medical, Dental & Lab Supply Marketplaces (CRAFAHAG)

Keywords

• Traditional Chinese medicine
• Chain pharmacy services
• Digital health platform
• AI medical diagnostics
• Property development

Headquarters

HQ city

Causeway Bay

HQ country

Hong Kong SAR China

HQ region

Asia

Offices6 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure, Technology or R&D, Others

Revenue model

1. Property Development (物业发展): Traditional real estate development and sales in mainland China cities. Revenue decreased significantly in FY2023 due to reduced deliveries. As of FY2022, the company achieved approximately RMB 648 million profit turnaround. FY2023 revenue was RMB 5.175 billion with RMB 1.02 billion profit.
2. Digital E-commerce & ICT Distribution: E-commerce business operating as a 'super brand digital operations partner', providing full-chain online operations and sales services for brand manufacturers and e-commerce platforms. Revenue of approximately RMB 1.907 billion in FY2023. Partners include 九阳, 格兰仕, 夏普, 凯伊秀, 元本生活.
3. Healthcare & Pharmacy (葉開泰): Revenue from chain pharmacy operations, TCM clinics, medical aesthetics, and online health services. Acquired 武汉叶开泰药业连锁 in November 2023. Contributed approximately RMB 14.025 million from acquisition date to September 2023. Revenue from medical aesthetics clinic (DAS Skin Clinic collaboration) and AI-powered pharmacy services.
4. Property Investment & Management: Rental income from commercial properties and property management services. H1 FY2023 (to September 2023) revenue of approximately RMB 48.717 million, up 58.7% YoY, driven by increased leasable floor area.
5. Asset Management (Hong Kong Type 9 License): Asset management services including SPV asset management, special opportunity asset investment and management, targeting distressed assets and real estate asset packages, leveraging the Hong Kong SFC Type 9 license obtained in April 2023.
6. NFT Digital Assets & Virtual Property: Revenue from NFT digital collectible issuance (滋圆 series - 999 units sold at RMB 61.8 each), virtual asset integration into property development, and virtual world platform participation.

Pricing tiers

Go-to-market motion3 records

Distribution channels7 records

Marketing channels7 records

Core offering

Peking University Resources (Holdings) is a Hong Kong-listed diversified conglomerate operating five business divisions: (1) traditional Chinese medicine healthcare through the 400-year-old 叶开泰 brand via chain pharmacies and TCM clinics; (2) digital health platforms (ResoHealth LetsGo, 叶开泰健康 AI mini-program) combining TCM with AI diagnostics; (3) real estate development and property management; (4) digital e-commerce and ICT distribution serving as a "super brand digital operations partner" for brands like 九阳, 格力, and 夏普; and (5) asset management under Hong Kong SFC Type 9 license. The company sells TCM products, pharmacy services, AI health consultations, property units, e-commerce marketing services, and NFT digital collectibles.

Product overview

Peking University Resources (Holdings) Company Limited operates as a diversified conglomerate with strategic focus on healthcare and digital transformation. The product portfolio centers on 葉開泰·健康 (Ye Kai Tai Health), a core brand based on the 387-year-old traditional Chinese medicine heritage of 葉開泰, which was established in 1637 and ranks among China's four famous traditional Chinese medicine pharmacies alongside Beijing Tongrentang, Hangzhou Hu Qing Yu Tang, and Guangzhou Chen Li Ji. The company offers physical services through 41 chain pharmacies and 11 TCM clinics in Wuhan, plus a clinic in Hangzhou. The digital health ecosystem includes the ResoHealth overseas health platform with LetsGo digital health platform (offering DNA epigenetic testing + AI, VIGOROUS AI management platform, insurance brokerage, and data services), the 叶开泰健康 AI-powered mini-program for smart TCM consultations, and the 源空间RH mini-program for marketing and referrals. Digital assets include the Captain源 super IP character and 滋圆 NFT digital collectibles. The company also maintains legacy real estate operations and ICT distribution businesses, while pursuing digital transformation through metaverse (Nibiru) and Web3.0 initiatives.

Differentiator

Problem solved

Functional benefit

Products and services

• 叶开泰·健康 (Ye Kai Tai Health) Primary healthcare brand of the company, based on the nearly 400-year-old traditional Chinese medicine heritage of 叶开泰. Offers comprehensive health services including pharmacy chain, TCM clinics, medical aesthetics, and digital health platforms.
• 叶开泰连锁药店 (Yekaitai Chain Pharmacy) Chain pharmacy business with over 40 stores in Wuhan, 11 TCM clinics, and 1 distribution center. Provides western and Chinese medicine dispensing, health consultations, and pharmacy services.
• 叶开泰中医诊疗馆 (Yekaitai TCM Clinics) Traditional Chinese medicine clinics offering diagnosis and treatment services, with presence in Wuhan and Hangzhou, including integrated Western-Chinese medicine outpatient clinic.
• ResoHealth Innovative digital health technology enterprise focused on digital health management. Strategically invested by PKU Resources Holdings (00618.HK), developing the LetsGo digital health platform with DNA epigenetics + AI technology for global users.
• LetsGo Digital Health Platform (LetsGo数字健康平台) Core digital health management platform featuring DNA epigenetic testing + AI, VIGOROUS AI management platform, insurance brokerage services, and data asset management. Provides four-in-one health ecosystem covering screening, intervention, insurance, and data.
• 叶开泰健康数智小程序 (Yekaitai Health AI Mini-Program) AI-powered WeChat mini-program integrating traditional Chinese medicine with AI technology for smart diagnosis and healthcare services, enabling intelligent medical consultations and health management.
• 叶开泰医疗美容皮肤科 (Yekaitai Medical Aesthetics Dermatology Clinic) Medical aesthetics and dermatology clinic in Wuhan offering chronic disease management, skin comprehensive care, and hair loss treatment services, in partnership with Singapore DAS Skin Clinic.
• Property Development and Management Real estate development in mainland China cities (Kunming, Qingdao, etc.) and commercial property management including Resource Boya Plaza office building operations. H1 FY2023 property management revenue rose 58.7% YoY to RMB 48.7 million.
• Digital E-commerce and Brand Operations Services E-commerce segment serves as a "super brand digital operations partner" for multiple domestic and international brands providing full-chain operations, digital marketing, and sales services across 32+ cities with 10,000+ channel partners.
• Nibiru Metaverse Platform (Nibiru元宇宙平台) Blockchain-based metaverse platform for virtual real estate development. Resource Holdings invested up to USD 2 million to develop metaverse real estate experiences using virtual human and scene technology.
• 滋圆 NFT Digital Collectibles (滋圆NFT数字藏品) NFT digital collection series featuring Captain源 IP with self-benefiting rights and blind box gameplay. Three themed series: 赛博次元, 雾都次元, 丹青次元. Limited to 999 pieces at RMB 61.8 each.
• Asset Management Services (Hong Kong SFC Type 9) Asset management services including SPV asset management, special opportunity asset investment and management, targeting distressed assets and real estate asset packages, leveraging the Hong Kong SFC Type 9 license.

Quantifiable outcome

• FY2023 profit of RMB 1.02 billion, representing 334.93% increase YoY, achieving turnaround from prior year losses
• +6 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability10 records

Feature5 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• 杭州 (Hangzhou municipal government)coreStrategic or Co-development Partner · 1 October 2025Strategic cooperation with Hangzhou for the 葉開泰 Hangzhou National Medical Hall (杭州国医馆), establishing a technology-driven healthcare health new height in Hangzhou. The clinic opened in October 2024 as a model for integrating traditional Chinese medicine with modern healthcare technology.
• 医联集团 (MedGPT)coreTechnology or Integration · 5 August 2024Deep strategic partnership for AI-powered medical services. 医联集团, a leading Chinese internet hospital founded in 2014, will integrate its MedGPT AI medical platform with 資源控股's 葉開泰 chain pharmacies. Key areas include: AI medical platform co-development, O2O integrated online-offline medical services, AI medical international expansion (MedGPT overseas), and precision medicine/health data services. This partnership was announced via official announcement on August 5, 2024.
• 新加坡DAS Skin CliniccoreStrategic or Co-development Partner · 5 March 2024Joint开设葉開泰医疗美容皮肤科 in Wuhan's Hankou CBD (江汉路). DAS Skin Clinic from Singapore provides advanced management model, clinical diagnosis concepts, overseas-certified physicians, and medical aesthetic technology. The clinic offers chronic disease management, skin comprehensive management, and hair loss treatment services combining TCM and Western medicine approaches.
• 新加坡DASSKINcoreStrategic or Co-development Partner · 1 January 2024Strategic cooperation with Singapore DASSKIN for overseas AI medical market expansion, enabling 資源控股 to develop global AI medical business through health technology integration.
• 九阳 (Jiuyang)coreChannel Partner/ Reseller/ Distributor · 31 March 2023Strategic brand partnership for digital commerce. 资源信产 (information technology subsidiary) provides digital marketing and distribution services for 九阳, including for overseas markets. During 2023 Double 11, 九阳 water purifiers achieved over 40% YoY growth on JD.com.
• 格兰仕, 夏普, 凯伊秀, 元本生活 (Gree, Sharp, Keyixiu, Yuanben Life)coreChannel Partner/ Reseller/ Distributor · 1 January 2023E-commerce segment serves as 'super brand digital operations partner' for multiple domestic and international brands including 格兰仕 (Gree appliances), 夏普 (Sharp electronics), 凯伊秀 (Keyixiu beauty), and 元本生活 (Yuanben Life). Services include IT solutions, digital content marketing, and full-chain operational support.
• 德勤 (Deloitte)minorImplementation/ SI/ Consulting Partner · 1 January 2022Deloitte served as liquidator of predecessor company and provided restructuring advisory services during the 500-day resumption process. Deloitte also conducted independent internal control reviews as part of the resumption compliance requirements.

Scale indicators12 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Laobaixing Pharmacy Chain JSC: Laobaixing is a major listed Chinese pharmacy chain with national store coverage. Comparable to Ye Kai Tai's pharmacy chain expansion approach, particularly in the consumer pharmacy retail and TCM-adjacent product categories.
• Beijing Tongrentang Co., Ltd. Beijing Tongrentang is one of China's four great TCM pharmacies alongside Ye Kai Tai and operates chain pharmacies, TCM clinics, and TCM product manufacturing. It is the most direct comparable in the legacy TCM pharmacy chain and consumer health segments, with broad product overlap and similar brand heritage dynamics.
• Yifeng Pharmacy Chain Co., Ltd. Yifeng Pharmacy is one of China's largest listed retail pharmacy chains, operating thousands of stores. It is a direct comparable for Ye Kai Tai's chain pharmacy segment in terms of scale, retail pharmacy business model, and consumer health product breadth across China.
• China Traditional Chinese Medicine Holdings Co., Ltd. China Traditional Chinese Medicine is a major listed TCM manufacturer and distributor with strong pharmaceutical-grade TCM product lines. It is comparable in terms of TCM focus and corporate heritage, though more upstream/manufacturing oriented than PKURH's pharmacy retail and clinic focus.

Broad incumbents

• JD Health International Inc. JD Health is a leading online healthcare and pharmacy retailer in China with a capital-intensive platform model. It is comparable to PKURH's digital health + pharmacy distribution strategy, particularly as the company already operates JD.com self-operated stores, and represents a much larger incumbent with deeper data and logistics assets.
• Alibaba Health Information Technology Limited: Alibaba Health operates the Tmall/Ali Health pharmacy and healthcare platform, combining online pharmacy retail, TCM e-commerce, and digital health services. It is a comparable peer for PKURH's digital health + e-commerce convergence strategy, with significantly larger scale and platform-level data.
• Ping An Healthcare and Technology Company Limited: Ping An Good Doctor is a large incumbent in China's digital health and AI medical consultation space, with a national internet hospital platform, AI-assisted diagnosis, and insurance integration. It overlaps with ResoHealth/LetsGo's AI health platform strategy and offers a comparable corporate wellness and employer/insurer-facing proposition.
• China Resources Pharmaceutical Group Limited: China Resources Pharmaceutical is a large state-owned pharmaceutical conglomerate covering wholesale, retail, and TCM manufacturing. It is comparable as a diversified Chinese medicine and pharmaceutical distribution platform, though at significantly larger scale and with broader B2B distribution reach.

Emerging players

• Dingdang Health: Dingdang Health is an emerging online pharmacy and O2O healthcare delivery platform in China, combining pharmacy retail with digital health services. It is comparable to PKURH's pharmacy-plus-digital health convergence model, particularly for the Wuhan-based retail pharmacy and digital consultation offering.
• Yidu Tech Inc. Yidu Tech is a Chinese AI medical technology company focused on AI medical big data, clinical decision support, and healthcare analytics. It is comparable to PKURH's AI medical platform component (MedGPT integration, Vigorous AI), particularly in the B2B AI health infrastructure segment.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Peking University Resources (Holdings) Company Limited